FOGHORN THERAPEUTICS I
7.8900
07-أكتوبر-24 14:03:36
15 متأخرة بدقائق
الأسهم
+0.0600
+0.77%
نطاق اليوم
7.5000 - 7.9100
ISIN
N/A
المصدر
NASDAQ
-
Foghorn Therapeutics Announces Chief Scientific Officer Succession
10 يناير 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the H.C. Wainwright BioConnect Conference
07 يناير 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
13 ديسمبر 2021 06:00:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the 2021 Jefferies London Healthcare Conference
11 نوفمبر 2021 16:05:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Third Quarter 2021 Corporate Update
09 نوفمبر 2021 07:00:02 بحسب Nasdaq GlobeNewswire
-
19 أكتوبر 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate in Two Upcoming Virtual Investor Conferences
01 سبتمبر 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Announces First Patient Dosed in First-in-Human Clinical Trial of FHD-609
23 أغسطس 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Second Quarter 2021 Corporate Update
10 أغسطس 2021 07:00:02 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference
03 أغسطس 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021
09 يوليو 2021 08:36:31 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Host Research & Development Day Webinar on June 15th
08 يونيو 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Present in Two Upcoming Investor Conferences
26 مايو 2021 08:00:03 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Program of FHD-286
17 مايو 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Corporate Update
11 مايو 2021 07:00:02 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Appoints Ian Smith to its Board of Directors
28 أبريل 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Corporate Update
18 مارس 2021 08:00:00 بحسب Nasdaq GlobeNewswire
-
UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
11 مارس 2021 17:11:35 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Present Poster and Chair a Panel and at the AACR Annual Meeting 2021
11 مارس 2021 16:01:00 بحسب Nasdaq GlobeNewswire